Background
Thalassemia is a hereditary illness attributable to a defect in globin synthesis. This ends in erythrocyte membrane fluidity. Thalassemia permits erythrocytes to be damaged down simply, thereby reducing the extent of hemoglobin within the blood. This phenomenon will lead to persistent non-immune hemolytic anemia.1–3 Indonesia is without doubt one of the nations with a excessive prevalence variety of thalassemia. Information from the Thalassemia Middle, Cipto Mangunkusumo Hospital (RSCM) in 2016, confirmed that there have been 9.031 sufferers with thalassemia main, and this quantity is predicted to be greater since now we have excessive prevalence of thalassemia gene carriers that are asymptomatic and haven’t performed any premarital screening.4
Thalassemia main (TM) is characterised by extreme anemia requiring pink blood cell transfusions repeatedly for progress and survival.5 In the meantime, thalassemia intermedia (TI) has a medical spectrum or phenotype which varies extensively from requiring common blood transfusions (transfusion-dependent thalassemia/TDT) to not requiring common transfusions (non-transfusion-dependent thalassemia/NTDT). Usually, problems of extra iron load in TM are attributable to transfusion of pink blood cells, which can lead to organ toxicity attributable to free radicals, reactive oxygen species (ROS). Folks with TI are additionally susceptible to iron overload because of the elevated absorption of iron from the digestive tract.6
Extreme iron overload varieties non-transferrin-bound iron (NTBI) with probably the most poisonous labile plasma iron (LPI) fraction. Nonetheless, the NTBI examination has not been standardized and doesn’t but exist in Indonesia. Transferrin saturation (TS) can be utilized as a surrogate marker for NTBI examination.7 Moreover, NTBI ferrous iron (Fe II) induces the elevated manufacturing of ROS, particularly hydroxyl radicals (OH•) by the Fenton and Haber Weiss response.8,9 The shaped ROS will trigger lipid peroxidation (PL) cell membrane with one of many merchandise specifically malondialdehyde (MDA), which is poisonous and mutagenic. MDA is used as a biomarker of oxidative stress examination.10
Present research on oxidative stress reveals conflicting outcomes. Some research in pediatric and adults with beta-thalassemia discovered correlation between SF and MDA ranges.11,12 Nonetheless, totally different outcomes had been obtained by Al-Hakeim et al13 and Gunarsih et al, who discovered no correlation between SF and MDA. In the meantime, outcomes from the research by Cighetti et al14 confirmed a correlation between NTBI and MDA. Quite the opposite, Al-Hakeim, et al13 and Walter et al15 didn’t acquire the correlation between NTBI with MDA. These warrant additional research, particularly in grownup thalassemia sufferers since most research had been performed in pediatric inhabitants.
Common blood transfusion remedy of thalassemia causes iron overload that may induce the formation of ROS. Nonetheless, there is no such thing as a revealed knowledge concerning the impact of transfusion on modifications in oxidative stress. MDA was chosen as a marker of oxidative stress as a result of the sampling and examination strategies are comparatively straightforward. Due to this fact, this research goals to measure the change of MDA ranges as a biomarker of oxidative stress associated to the supply of blood transfusion remedy. Moreover, we additionally purpose to investigate the connection of iron overload and MDA degree in thalassemia sufferers each earlier than and after transfusion.
Strategies
Inhabitants
The focused inhabitants is grownup sufferers with beta-thalassemia in RSCM on the Thalassemia and Hematology Polyclinic, Division of Inside Medication. They obtained blood transfusions both repeatedly (thalassemia main or TDT-phenotype thalassemia intermedia) or as required (thalassemia minor or NTDT-phenotype thalassemia intermedia). Moreover, the chosen topics had been a those that met the inclusion standards of the research.
Inclusion Standards
The themes recruited had been aged 18 years or extra and had been recognized with beta-thalassemia with high-performance liquid chromatography (HPLC) or microcapillary technique. They had been prepared to take part within the research after signing a written consent type. Moreover, the topics that fulfilled inclusion standards had been categorized into TDT and NTDT teams.
Exclusion Standards
The sufferers who skilled acute medical circumstances (coronary heart failure, liver failure), acute irritation (temperature>38°C), persistent irritation or an infection, pregnant lady, and malignancy had been excluded.
Recruitment of Topics
The themes had been recruited consecutively from on the Thalassemia and Hematology Polyclinic, Division of Inside Medication, Cipto Mangunkusumo Nationwide Referral Hospital, Jakarta. Moreover, the demographic knowledge and the amount of blood and frequency of pink cell transfusions up to now yr had been recorded from the medical data of sufferers, and so they had been categorized into TDT and NTDT.
Laboratory Procedures
The sufferers underwent venous blood sampling twice, ie, earlier than and after blood transfusion. Subsequently, blood samples had been taken every as a lot as 12 mL and 5 mL, and the check for the worth of hemoglobin, serum ferritin, hsCRP, transferrin saturation, and malondialdehyde (MDA) was then performed.
Measurement of MDA was performed by spectrophotometric technique (Wills) utilizing the precept of the response with thiobarbituric acid. This process makes use of 3 mL of blood serum combined with trichloroacetic acid and was centrifuged to type a supernatant. Moreover, the supernatant or protein deposits had been added with acetic acid, thiobarbituric acid, and n-butanol to provide colours. The colour shaped is learn at a wavelength of 532 nm by spectrophotometry.
Ethics
This research has been reviewed and accepted by The Ethics Committee of the School of Medication, Universitas Indonesia, and the topics supplied acceptable consent to take part. This research was performed following the declaration of Helsinki, and all contributors had been knowledgeable concerning the objective of the research.
Information Evaluation
The collected knowledge had been processed utilizing SPSS 20 for Home windows. Information evaluation was performed utilizing the t-test/Mann–Whitney and Pearson/Spearman correlation check, relying on the info distribution.
Outcomes
Demographic Information
A complete of 63 grownup sufferers with beta-thalassemia had been recruited throughout this research interval, and it consisted of 51 TDT and 12 NTDT sufferers. There have been 37 females (58%) and 26 males (42%) topics, and the median age was 25 years with a variety from 18 to 67 years. Moreover, the variety of sufferers with beta-thalassemia was 21 (33%) and beta-thalassemia/HbE was 42 individuals (67%). Medical traits of topics with TDT had been nearly equal to sufferers with NTDT when it comes to the gender ratio, age, hemoglobin degree and physique mass index (BMI). Sufferers with TDT obtained a lot bigger and extra frequent blood transfusions than NTDT (Table 1).
 |
Desk 1 Traits of the Topics Research In accordance TDT and NTDT Teams Earlier than Transfusion |
Measurement of MDA Plasma
The median plasma MDA degree on the topics earlier than transfusion was 0.49 µmol/L with the bottom and the very best worth of 0.21 µmol/L and 1.33 µmol/L. In the meantime, the median plasma MDA degree after transfusion was 0.45 µmol/L with the bottom and highest worth of 0.14 µmol/L and 1.49 µmol/L, respectively.
Variations in Plasma MDA Ranges Between TDT and NTDT Teams
There have been no important variations in plasma MDA ranges earlier than and after transfusion in grownup sufferers with beta-thalassemia TDT and NTDT (Table 2).
 |
Desk 2 Plasma MDA Ranges Earlier than and After Transfusion in Grownup Sufferers with Beta-Thalassemia TDT and NTDT |
Plasma MDA Stage in Grownup Sufferers with Beta-Thalassemia TDT and NTDT Between Earlier than and After Transfusion
The evaluation confirmed that there was no important distinction within the change (delta) median plasma MDA ranges earlier than and after transfusion in grownup sufferers with beta-thalassemia TDT and NTDT (Table 3).
 |
Desk 3 Change (Delta) Plasma MDA Ranges in Grownup Sufferers with Beta-Thalassemia TDT and NTDT Between Earlier than and After Transfusion |
Correlation Between Serum Ferritin and Transferrin Saturation with Plasma MDA Ranges Earlier than and After Transfusion in Grownup Sufferers with Beta-Thalassemia TDT and NTDT
Earlier than transfusion, there was no correlation between SF and MDA, and TS and MDA ranges. After the transfusion, there was no correlation between, SF and MDA, or TS and MDA ranges in grownup sufferers with beta-thalassemia (TDT and NTDT) (Table 4).
 |
Desk 4 The Correlation Between Serum Ferritin and Transferrin Saturation with Plasma MDA Ranges Earlier than and After Transfusion |
Though Pearson correlation check confirmed important correlation between SF and MDA earlier than transfusion, the info distribution was not regular. Therefore, Spearman correlation was used and resulted in no correlation.
Modifications in Plasma MDA
The modifications in plasma MDA ranges in these two teams could be seen in Table 5 and Figure 1.
 |
Desk 5 The Proportion of Topics Based on Modifications of Plasma MDA Ranges Earlier than and After Transfusion in Grownup Sufferers with Thalassemia Beta TDT and NTDT |
 |
Determine 1 Line graph depicting the rise (left), stagnation (center), and reduce (proper) in MDA ranges between research topics, pre and publish transfusion. |
Dialogue
A complete of 63 sufferers had been included on this research, consisting of 51 TDT and 12 NTDT sufferers with a median age of 25 years outdated. Moreover, the median ranges of MDA had been 0.49 (min 0.21; max 1.33) µmol/L and weren’t considerably totally different between earlier than and after transfusion. Variations within the outcomes of plasma MDA ranges with earlier research could be assumed to be attributable to totally different topic traits. This consists of the usage of iron chelation remedy and antioxidant supplementation in addition to the strategies used within the measurement of MDA ranges. Plasma MDA degree tends to be elevated in thalassemia and this displays the oxidative stress standing of the sufferers.16 In comparison with wholesome controls, sufferers with thalassemia present elevated MDA ranges.16,17 The rise on this lipid peroxidation product is taken into account to be carefully associated to the diploma of oxidative stress as reported by Ozturk et al.18
The themes used iron chelation remedy and antioxidant supplementation repeatedly. A number of research have been performed on the impact of iron chelation and antioxidants on modifications in MDA ranges as a marker of oxidative stress. Plasma MDA ranges had been decreased on the topic approaching the degrees in wholesome controls after receiving iron chelation remedy and antioxidants for six–12 months.19,20 A research performed by Nasseri, et al21 confirmed that administration of antioxidants in thalassemia sufferers decreases MDA ranges. Due to this fact, plasma MDA ranges obtained on this research had been prone to be influenced by routine supplementation of antioxidants and iron chelation remedy.
Median ranges of MDA was not considerably totally different in sufferers with TDT and NTDT (0.55 vs 0.44 µmol/L; p = 0.100; Mann–Whitney check). The NTDT group consists of sufferers with thalassemia that obtained blood transfusions, however not repeatedly with a imply frequency of 4 transfusions per yr. Quite the opposite, TDT sufferers encompass beta-thalassemia main and TDT-phenotype thalassemia intermedia sufferers that require common blood transfusions. Nonetheless, this research reveals that the distinction of MDA ranges between TDT and NTDT teams was not important.
There was no correlation between SF and MDA ranges earlier than transfusion. Though Pearson check confirmed a big weak correlation, since our knowledge distribution was irregular, nonparametric check must be used. Spearman correlation check confirmed that there was no correlation between SF and MDA in addition to TS and MDA earlier than and after transfusion.
Related outcomes have been reported Gunarsih et al1 in youngsters with thalassemia main in the identical middle the place our research was performed. Of their research, the correlation between serum ferritin and plasma MDA focus was not obtained (r=0.147; p=0.285). As well as, a research performed by Al-Hakeim, et, al13 on 118 sufferers with beta-thalassemia main in youngsters age 4–12 years additionally confirmed no correlation between serum ferritin ranges of plasma MDA. Quite the opposite, one other research by Cighetti et al14 on 21 sufferers with beta-thalassemia main age 19–30 years and 13 with beta-thalassemia intermedia 23–46 years of age obtained a constructive correlation between complete MDA and NTBI (r=0.45; p=0.037). Nonetheless, in our research, we discovered no correlation between complete MDA and serum ferritin degree.
Malondialdehyde (MDA) is a well-established marker for oxidative stress and mobile harm. Oxidative stress occurs in lots of illness states similar to most cancers, persistent irritation, and thalassemia.22 Oxidative stress is a outcome from the imbalance of oxidants and antioxidants. When the steadiness tip in direction of oxidants (ie, inadequate antioxidant exercise), mobile harm happens. Moreover, the formation of reactive oxygen species (ROS) contributes to DNA harm, mobile damage, and even carcinogenesis.22 In thalassemia, iron overload performs a significant position in mediating oxidative stress.
There was no earlier research which correlated serum ferritin ranges and plasma MDA in serial sample earlier than and after transfusion. In 58% of TDT sufferers, MDA ranges decreased after transfusion. In the meantime, in NTDT, 55.6% had elevated MDA ranges. The absence of plasma MDA enhance after transfusion in some topics is perhaps associated to routine supplementation of antioxidants, which might attenuate the rise in MDA ranges. A research by Ezzat, et al23 confirmed that sufferers with thalassemia have diminished antioxidant exercise and vitamin E ranges. Due to this fact, routine supplementation of vitamin E or different antioxidants must be thought-about a rational strategy. In topics with elevated MDA ranges after transfusion, the supplementation of antioxidants might not be enough to suppress the oxidative stress harm. Due to this fact, antioxidants similar to vitamin E can be utilized to attenuate this course of.21 On this research, nearly all of sufferers had been routinely prescribed antioxidants.
In Islamic nations such because the Center East and Indonesia, there’s a follow of blood cupping known as Al-hijamah. Regardless that there is no such thing as a knowledge on the proportion of thalassemia sufferers that obtained this remedy, quite a lot of Indonesians observe the follow. Blood cupping is scientifically confirmed to scale back iron overload, serum ferritin, and oxidative stress.24 It removes MDA from circulating blood to scale back oxidative stress.25 Due to this fact, this technique could be thought-about in choose thalassemia sufferers, particularly in these with out thrombocytopenia attributable to hypersplenism. If thrombocytopenia has already occurred, blood cupping would possibly induce huge blood loss which can will increase the transfusional requirement.
One other concern of measuring plasma MDA degree after transfusion is the potential of interference from the donor’s MDA. Nonetheless, since leukodepleted or washed-packed pink cells are solely used for routine transfusion, the plasma content material of MDA must be negligible.
Moreover, the transferrin saturation didn’t correlate with plasma MDA ranges both earlier than or after transfusion. Transferrin saturation is a surrogate marker for NTBI. NTBI is the gold customary for measuring iron overload, though the examination is just not out there in Indonesia. Due to this fact, transferrin saturation was employed as a substitute of NTBI, and there was no correlation between FS and TS with MDA ranges. Due to this fact, additional research ought to measure NTBI as a substitute of FS and TS as markers of iron overload. When it comes to oxidative stress, as well as of malondialdehyde, exercise of different aldehydes could be measured through the use of assay for thiobarbituric acid reactive species.26
The pattern dimension used is bigger than comparable research performed in Pakistan and Egypt.23,27 Furthermore, the novelty of this research is the actual fact the MDA ranges had been measured pre- and post-transfusion. That is the primary research that employed serial measurements of MDA ranges. Limitation of this research is the restricted variety of contributors because of the quick research interval and price range restrictions since MDA-level assay will not be coated by nationwide medical health insurance. Additional research involving a bigger pattern dimension is inspired to verify our findings. Furthermore, it ought to contain sufferers with thalassemia main, intermedia, minor, and regular management group to match the connection between blood transfusion, iron overload, and oxidative stress. As well as, the topics must be stratified primarily based on baseline SF and TS to detect the distinction in MDA ranges.
Conclusion
Median plasma MDA ranges in grownup beta-thalassemia main and intermedia earlier than and after transfusion had been 0.49 µmol/L and 0.45 µmol/L, respectively. There was no important distinction between MDA ranges and between TDT and NTDT sufferers. Moreover, there was no correlation between FS and TS with MDA earlier than and after transfusion. The routine administration of antioxidants, particularly vitamin E, would possibly play a task in ameliorating MDA in thalassemia sufferers. Due to this fact, though blood transfusion will increase iron load in thalassemia sufferers, there was no enhance in median MDA degree after transfusion.
Disclosure
The authors report no conflicts of curiosity for this work.
References
1. Gunarsih A, Amalia P, Boediman I. Variables related to malondialdehyde degree in sufferers with thalassemia main. Paediatr Indones. 2012;52:125–131. doi:10.14238/pi52.3.2012.125-31
2. Cappellini MD, Cohen A, Porter J, et al. Tips for the Administration of Transfusion-Dependent Thalassemia. Thalassemia Worldwide Federation; 2014.
3. Gamberini MR, De Sanctis V, Gilli G. Hypogonadism, diabetes mellitus, hypothyroidism, hypoparathyroidism: incidence and prevalence associated to iron overload and chelation remedy in sufferers with thalassaemia main adopted from 1980 to 2007 within the Ferrara Centre. Pediatr Endocrinol Rev. 2008;6(Suppl 1):158–169.
4. Thalassemia Middle Cipto Mangunkusumo Hospital. Thalassemia main sufferers knowledge. Jakarta; 2016. [unpublished document].
5. Wooden B, Molecular Higgs D. Foundation of thalassemia syndromes. Problems of erythropoiesis, erythrocytes and iron metabolism. Eur Sch Hematol. 2009;35:406
6. Taher AT, Vichinsky E, Musallam Ea Okay. Tips for the Administration of Non-Transfusion Dependent Thalassemia (NTDT). Thalassemia Worldwide Federation; 2013.
7. Kohgo Y, Ikuta Okay, Ohtake T, et al. Physique iron metabolism and pathophysiology of iron overload. Int J Hematol. 2008;88(1):7–15. doi:10.1007/s12185-008-0120-5
8. Hershko C. Pathogenesis and administration of iron toxicity in thalassemia. Ann N Y Acad Sci. 2010;1202:1–9. doi:10.1111/j.1749-6632.2010.05544.x
9. Kalpravidh RW, Siritanaratkul N, Insain P, et al. Enchancment in oxidative stress and antioxidant parameters in beta-thalassemia/Hb E sufferers handled with curcuminoids. Clin Biochem. 2010;43(4–5):424–429. doi:10.1016/j.clinbiochem.2009.10.057
10. Nielsen F, Mikkelsen BB, Nielsen JB, et al. Plasma malondialdehyde as biomarker for oxidative stress: reference interval and results of life-style components. Clin Chem. 1997;43(7):1209–1214. doi:10.1093/clinchem/43.7.1209
11. Sengsuk C, Tangvarasittichai O, Chantanaskulwong P, et al. Affiliation of iron overload with oxidative stress, hepatic harm and dyslipidemia in transfusion-dependent β-Thalassemia/HbE sufferers. Indian J Clin Biochem. 2014;29(3):298–305. doi:10.1007/s12291-013-0376-2
12. Naithani R, Chandra J, Bhattacharjee J, et al. Peroxidative stress and antioxidant enzymes in youngsters with beta-thalassemia main. Pediatr Blood Most cancers. 2006;46(7):780–785. doi:10.1002/pbc.20669
13. Al-Hakeim HK, Auda FM, Ali BM. Lack of correlation between non-labile iron parameters, complete carbonyl and malondialdehyde in main thalassemia. J Clin Biochem Nutr. 2014;55(3):203–206. doi:10.3164/jcbn.14-24
14. Cighetti G, Duca L, Bortone L, et al. Oxidative standing and malondialdehyde in beta-thalassaemia sufferers. Eur J Clin Make investments. 2002;32(Suppl 1):55–60. doi:10.1046/j.1365-2362.2002.0320s1055.x
15. Walter PB, Macklin EA, Porter J, et al. Irritation and oxidant-stress in beta-thalassemia sufferers handled with iron chelators deferasirox (ICL670) or deferoxamine: an ancillary research of the Novartis CICL670A0107 trial. Haematologica. 2008;93(6):817–825. doi:10.3324/haematol.11755
16. Boudrahem-Addour N, Izem-Meziane M, Bouguerra Okay, et al. Oxidative standing and plasma lipid profile in β-Thalassemia sufferers. Hemoglobin. 2015;39(1):36–41. doi:10.3109/03630269.2014.979997
17. Abduljabbar A, Mehmetçik G. Malondialdehyde and C-Reactive protein values in transfusion dependent thalassemia sufferers; 2018.
18. Ozturk Z, Genc GE, Kupesiz A, et al. Thalassemia main sufferers utilizing iron chelators confirmed a diminished plasma thioredoxin degree and diminished thioredoxin reductase exercise, regardless of elevated oxidative stress. Free Radic Res. 2015;49(3):309–316. doi:10.3109/10715762.2015.1004327
19. Yanpanitch OU, Hatairaktham S, Charoensakdi R, et al. Remedy of β-Thalassemia/Hemoglobin E with antioxidant cocktails ends in decreased oxidative stress, elevated hemoglobin focus, and enchancment of the hypercoagulable state. Oxid Med Cell Longev. 2015;2015:537954. doi:10.1155/2015/537954
20. Tesoriere L, D’Arpa D, Maggio A, et al. Oxidation resistance of LDL is correlated with vitamin E standing in beta-thalassemia intermedia. Atherosclerosis. 1998;137(2):429–435. doi:10.1016/s0021-9150(97)00300-6
21. Nasseri E, Mohammadi E, Tamaddoni A, et al. Advantages of curcumin supplementation on antioxidant standing in β-thalassemia main sufferers: a double-blind randomized managed medical trial. Ann Nutr Metab. 2017;71(3–4):136–144. doi:10.1159/000479634
22. Maurya RP, Prajapat MK, Singh VP, et al. Serum malondialdehyde as a biomarker of oxidative stress in sufferers with major ocular carcinoma: impression on response to chemotherapy. Clin Ophthalmol. 2021;15:871–879. doi:10.2147/OPTH.S287747
23. Ezzat AM, Abdelmotaleb GS, Shaheen AM, et al. Peroxidative stress and antioxidant enzymes in youngsters with beta-thalassemia main. Med Res J. 2016;15(2):57–62. doi:10.1097/01.MJX.0000511315.53248.78
24. El-Shanshory M, Hablas NM, Shebl Y, et al. Al-hijamah (moist cupping remedy of prophetic drugs) considerably and safely reduces iron overload and oxidative stress in thalassemic youngsters: a novel pilot research. J Blood Med. 2018;9:241–251. doi:10.2147/JBM.S170523
25. Almaiman AA. Proteomic results of moist cupping (Al-hijamah). Saudi Med J. 2018;39(1):10–16. doi:10.15537/smj.2018.1.21212
26. Ondei L, Estevão I, Rocha MIP, et al. Oxidative stress and antioxidant standing in beta-thalassemia heterozygotes. Rev Bras Hematol Hemoter. 2013;35(6):409–413. doi:10.5581/1516-8484.20130122
27. Rasool M, Malik A, Jabbar U, et al. Impact of iron overload on renal capabilities and oxidative stress in beta thalassemia sufferers. Saudi Med J. 2016;37(11):1239–1242. doi:10.15537/smj.2016.11.16242
